Zelen, Charles |
NCT06319287: Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU) |
|
|
| Recruiting | 2 | 40 | US | PEP (Purified Exosome Product) / TISSEEL, Extracellular Vesicles | Rion Inc., Professional Education and Research Institute | Diabetic Foot Ulcer | 04/25 | 07/25 | | |
BGWM, NCT06403605: Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers |
|
|
| Recruiting | N/A | 100 | US | Mirragen Wound Matrix, Fibracol | ETS Wound Care, LLC, Professional Education and Research Institute | Diabetic Foot Ulcer, Ulcer Foot, Diabetic Foot | 12/24 | 12/24 | | |
NCT05797285: Evaluating The Efficacy Of A Keratin Graft In Treating Non-Healing Diabetic Foot Ulcers |
|
|
| Completed | N/A | 26 | US | human keratin graft, ProgenaMatrix | ProgenaCare Global, LLC, Professional Education and Research Institute | Ulcer Healing, Diabetic Foot Ulcer | 12/23 | 12/23 | | |
DFUs, NCT05506215: Randomized Clinical Study Comparing SynPath to Standard of Care in Treatment of Chronic Diabetic Foot Ulcers |
|
|
| Terminated | N/A | 25 | US | SynPath Acellular Dermal Matrix plus Off-loading Device, Wound Dressing composed of 90% collagen and 10% Alginate plus Off-loading Device | PolyNovo Biomaterials Pty Ltd. | Diabetic Foot, Chronic Foot Ulcer, Wound Healing, Foot Ulcer | 02/24 | 02/24 | | |
NCT06557122: Clinical Study to Compare Two Skin Substitute Categories for Their Effectiveness to Treat Diabetic Foot Ulcers |
|
|
| Completed | N/A | 24 | US | SOC and Advanced Bioengineered Skin Substitute, SOC and Active Comparator | Encoll Corp | Diabetic Foot Ulcer | 10/24 | 10/24 | | |
SKY-WP-VLU-02, NCT06764953: Clinical Trial Evaluating an Amnion Membrane Allograft Intended for Use in the Management of Non- Healing Venous Leg Ulcers Versus Standard Of Care Alone |
|
|
| Recruiting | N/A | 100 | US | E-GRAFT ™, FIBRACOL™ | Skye Biologics Holdings, LLC | Venous Leg Ulcers | 12/25 | 12/25 | | |
SKY-WP-DFU-02, NCT06767501: Clinical Trial Evaluating an Amnion Membrane Allograft for Use in the Management of Non- Healing Diabetic Foot Ulcers Versus Standard Of Care |
|
|
| Recruiting | N/A | 100 | US | E-GRAFT ™, FIBRACOL™ | Skye Biologics Holdings, LLC | Diabetic Foot Ulcers (DFUs) | 12/25 | 12/25 | | |